Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects

Alzheimer's and Dementia

Volumn 10, Issue 2, 2014, Pages 205-213

  Pedraza, Otto ^a   Allen, Mariet ^a   Jennette, Kyle ^a   Carrasquillo, Minerva ^a   Crook, Julia ^a   Serie, Daniel ^a   Pankratz, V Shane ^b   Palusak, Ryan ^a   Nguyen, Thuy ^a   Malphrus, Kimberly ^a   Ma, Li ^a   Bisceglio, Gina ^a   Roberts, Rosebud O ^b   Lucas, John A ^a   Ivnik, Robert J ^b   Smith, Glenn E ^b   Graff Radford, Neill R ^a   Petersen, Ronald C ^b   Younkin, Steven G ^a   Ertekin Taner, Nilüfer ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Alzheimer's disease; Association; CLU; CR1; Endophenotypes; Genetic; Memory; PICALM

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CAUCASIAN; CLU GENE; CONTROLLED STUDY; CR1 GENE; ENDOPHENOTYPE; EPISODIC MEMORY; FEMALE; GENE; GENE LOCUS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MIDDLE AGED; NEGRO; PICALM GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY;

ALZHEIMER'S DISEASE; ASSOCIATION; CLU; CR1; ENDOPHENOTYPES; GENETIC; MEMORY; PICALM;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; CLUSTERIN; ENDOPHENOTYPES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MEMORY; MIDDLE AGED; MONOMERIC CLATHRIN ASSEMBLY PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, COMPLEMENT 3B;

EID: 84897516307     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2013.01.016     Document Type: Article

References (31)

1. D. Harold, R. Abraham, P. Hollingworth, R. Sims, A. Gerrish, and M.L. Hamshere et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease Nat Genet 2009
2. J.C. Lambert, S. Heath, G. Even, D. Campion, K. Sleegers, and M. Hiltunen et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease Nat Genet 41 2009 1094 1099
3. S. Seshadri, A.L. Fitzpatrick, M.A. Ikram, A.L. DeStefano, V. Gudnason, and M. Boada et al. Genome-wide analysis of genetic loci associated with Alzheimer disease JAMA 303 2010 1832 1840
4. P. Hollingworth, D. Harold, R. Sims, A. Gerrish, J.C. Lambert, and M.M. Carrasquillo et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease Nat Genet 43 2011 429 435
5. A.C. Naj, G. Jun, G.W. Beecham, L.S. Wang, B.N. Vardarajan, and J. Buros et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease Nat Genet 43 2011 436 441
6. I.I. Gottesman, and T.D. Gould The endophenotype concept in psychiatry: etymology and strategic intentions Am J Psychiatry 160 2003 636 645
7. C.E. Bearden, and N.B. Freimer Endophenotypes for psychiatric disorders: ready for primetime? Trends Genet 22 2006 306 313
8. D.C. Glahn, L. Almasy, J. Blangero, G.M. Burk, J. Estrada, and J.M. Peralta et al. Adjudicating neurocognitive endophenotypes for schizophrenia Am J Med Genet B Neuropsychiatr Genet 144 2007 242 249
9. N. Ertekin-Taner Gene expression endophenotypes: a novel approach for gene discovery in Alzheimer's disease Mol Neurodegener 6 2011 31
10. D.A. Bennett, P.L. De Jager, S.E. Leurgans, and J.A. Schneider Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles Neurology 72 2009 1495 1503
11. C.R. Jack Jr., D.S. Knopman, W.J. Jagust, L.M. Shaw, P.S. Aisen, and M.W. Weiner et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Lancet Neurol 9 2010 119 128
12. R.J. Caselli, E.M. Reiman, D.E. Locke, M.L. Hutton, J.G. Hentz, and C. Hoffman-Snyder et al. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment Arch Neurol 64 2007 1306 1311
13. R.J. Caselli, A.C. Dueck, D. Osborne, M.N. Sabbagh, D.J. Connor, and G.L. Ahern et al. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect N Engl J Med 361 2009 255 263
14. L.B. Chibnik, J.M. Shulman, S.E. Leurgans, J.A. Schneider, R.S. Wilson, and D. Tran et al. CR1 is associated with amyloid plaque burden and age-related cognitive decline Ann Neurol 69 2011 560 569
15. B.T. Keenan, J.M. Shulman, L.B. Chibnik, T. Raj, D. Tran, and M.R. Sabuncu et al. A coding variant in CR1 interacts with APOE-epsilon4 to influence cognitive decline Hum Mol Genet 21 2012 2377 2388
16. S. Barral, T. Bird, A. Goate, M.R. Farlow, R. Diaz-Arrastia, and D.A. Bennett et al. Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory Neurology 78 2012 1464 1471
17. G. Hamilton, S.E. Harris, G. Davies, D.C. Liewald, A. Tenesa, and J.M. Starr et al. Alzheimer's disease genes are associated with measures of cognitive ageing in the Lothian birth cohorts of 1921 and 1936 Int J Alzheimers Dis 2011 2011 505984
18. B.F. Verhaaren, M.W. Vernooij, P.J. Koudstaal, A.G. Uitterlinden, C.M. Duijn, and A. Hofman et al. Alzheimer's disease genes and cognition in the nondemented general population Biol Psychiatry 2012
19. R.O. Roberts, Y.E. Geda, D.S. Knopman, R.H. Cha, V.S. Pankratz, and B.F. Boeve et al. The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics Neuroepidemiology 30 2008 58 69
20. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease Neurology 34 1984 939 944
21. D.A. Wechsler Wechsler Memory Scale-revised 1987 Psychological Corporation New York
22. M.M. Carrasquillo, F. Zou, V.S. Pankratz, S.L. Wilcox, L. Ma, and L.P. Walker et al. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease Nat Genet 41 2009 192 198
23. S. Purcell, B. Neale, K. Todd-Brown, L. Thomas, M.A. Ferreira, and D. Bender et al. PLINK: a tool set for whole-genome association and population-based linkage analyses Am J Hum Genet 81 2007 559 575
24. G.S. Wilkinson Wide-Range Achievement Test Revision-3 1993 Jastak Association
25. J.J. Manly, D.M. Jacobs, P. Touradji, S.A. Small, and Y. Stern Reading level attenuates differences in neuropsychological test performance between African American and white elders J Int Neuropsychol Soc 8 2002 341 348
26. O. Pedraza, and D. Mungas Measurement in cross-cultural neuropsychology Neuropsychology Rev 18 2008 184 193
27. A. Ward, S. Crean, C.J. Mercaldi, J.M. Collins, D. Boyd, and M.N. Cook et al. Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: a systematic review and meta-analysis Neuroepidemiology 38 2012 1 17
28. S. Zollner, and J.K. Pritchard Overcoming the winner's curse: estimating penetrance parameters from case-control data Am J Hum Genet 80 2007 605 615
29. T. Nuutinen, T. Suuronen, A. Kauppinen, and A. Salminen Clusterin: a forgotten player in Alzheimer's disease Brain Res Rev 61 2009 89 104
30. M. Allen, F. Zou, H.S. Chai, C.S. Younkin, J. Crook, and V.S. Pankratz et al. Novel late-onset Alzheimer's disease loci variants associate with brain gene expression Neurology 2012
31. I.F. Ling, J. Bhongsatiern, J.F. Simpson, D.W. Fardo, and S. Estus Genetics of clusterin isoform expression and Alzheimer's disease risk PLoS One 7 2012 e33923